Infinity Pharmaceuticals, Inc.
TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
Last updated:
Abstract:
Provided herein are methods, kits, and pharmaceutical compositions that include a P13 kinase inhibitor for treating cancers or hematologic disorders.
Status:
Application
Type:
Utility
Filling date:
14 Apr 2020
Issue date:
4 Mar 2021